Wire flash
HealthCongo Ebola death toll tops 1,400 as vaccine trials begin
Editorial responsibility
- No named human review is recorded for this page.
- Source reporting is collected, normalized, translated or condensed automatically when needed.
- Automatically published source-backed update
The Ebola outbreak in the Democratic Republic of Congo has escalated dramatically, with the death toll surpassing 1,400 and confirmed cases reaching 3,200. The virus is described as 'spreading like a wildfire,' particularly affecting crowded camps. Vaccine trials have begun in an effort to contain the outbreak. The situation is compounded by health workers going on strike, which hampers response efforts. Multiple news outlets, including DW.com, Al Jazeera, AP News, The New York Times, and Reuters, report on the worsening crisis, highlighting the urgent need for containment and treatment measures.
Source report
The Ebola outbreak in the Democratic Republic of Congo (DRC) continues to escalate, with the death toll exceeding 1,400 and confirmed cases nearing 3,200, according to multiple news reports.
Key Developments
- Death toll: The number of Ebola-related deaths has surpassed 1,400, with Reuters reporting 1,405 deaths among 3,200 confirmed cases.
- Case count: The DRC government has confirmed that the number of Ebola cases has risen to 3,200.
- Vaccine trials: Vaccine trials have commenced as part of the ongoing response to the outbreak.
Situation on the Ground
- Spreading rapidly: Al Jazeera reports that the virus is "spreading like a wildfire," with deaths surging past 1,300.
- Health worker strikes: AP News notes that more health workers are going on strike as cases near 3,000, including over 1,300 deaths.
- Crowded camps: The New York Times highlights the dire situation in crowded camps, quoting residents who fear widespread infection: "We will all die from Ebola here."
Sources
- DW.com
- Al Jazeera
- AP News
- The New York Times
- Reuters
Source
Top stories - Google NewsWestern
Part of this Story
Congo Ebola Death Toll Tops 1,400 as Vaccine Trials Start